Detalhe da pesquisa
1.
Freddie: annotation-independent detection and discovery of transcriptomic alternative splicing isoforms using long-read sequencing.
Nucleic Acids Res
; 51(2): e11, 2023 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478271
2.
SMAD3 promotes expression and activity of the androgen receptor in prostate cancer.
Nucleic Acids Res
; 51(6): 2655-2670, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727462
3.
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.
Proc Natl Acad Sci U S A
; 119(4)2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064078
4.
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
Proc Natl Acad Sci U S A
; 118(13)2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753479
5.
Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
Proc Natl Acad Sci U S A
; 116(29): 14573-14582, 2019 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266892
6.
Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
Proc Natl Acad Sci U S A
; 115(20): E4584-E4593, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29712835
7.
miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
Prostate
; 80(9): 674-686, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294305
8.
The Use of Methods of Computer-Aided Drug Discovery in the Development of Topoisomerase II Inhibitors: Applications and Future Directions.
J Chem Inf Model
; 60(8): 3703-3721, 2020 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32687346
9.
Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer.
Cancer Sci
; 110(1): 245-255, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30417466
10.
SRRM4 gene expression correlates with neuroendocrine prostate cancer.
Prostate
; 79(1): 96-104, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30155992
11.
Molecular model for neuroendocrine prostate cancer progression.
BJU Int
; 122(4): 560-570, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29569310
12.
Tyrosine Residues Regulate Multiple Nuclear Functions of P54nrb.
J Cell Physiol
; 232(4): 852-861, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27430900
13.
The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors.
Int J Cancer
; 136(4): E27-38, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25138562
14.
Progesterone receptor expression during prostate cancer progression suggests a role of this receptor in stromal cell differentiation.
Prostate
; 75(10): 1043-50, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25833156
15.
PDIA2 has a dual function in promoting androgen deprivation therapy induced venous thrombosis events and castrate resistant prostate cancer progression.
Oncogene
; 43(21): 1631-1643, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589675
16.
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression.
J Natl Cancer Inst
; 116(3): 421-433, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847647
17.
The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy.
Pharmaceuticals (Basel)
; 16(1)2023 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36678591
18.
TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer.
Oncogene
; 42(8): 559-571, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36544044
19.
Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer.
Oncogene
; 42(26): 2126-2138, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37198397
20.
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.
Nat Commun
; 14(1): 252, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650183